MedPath

BRAVA: Building Resilience and Attachment in Vulnerable Adolescents

Not Applicable
Completed
Conditions
Suicidal Ideation
Suicide and Self-harm
Interventions
Other: Group Intervention
Behavioral: Enhanced Treatment as Usual
Registration Number
NCT04751968
Lead Sponsor
Children's Hospital of Eastern Ontario
Brief Summary

The prevalence of suicidal ideation (SI) among adolescents in North America is high, making it critical to develop evidence-based brief interventions for adolescents with SI that target healthy coping skills and relationships. BRAVA is a novel brief group intervention for adolescents with mild to moderate SI and their caregivers; youth are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The goal of the randomized controlled trial is to assess the efficacy of a virtually-delivered, brief group intervention for adolescents with mild to moderate SI and their caregivers in reducing SI.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • Adolescents 13 years old to 17.5 years old
  • Mild to moderate suicidal ideation (SI without plan or gesture; 1 on the HEADS-ED) (Cappelli, et al., 2012)
  • Interested in study participation
  • Access to an electronic device with internet and email capabilities, and a functioning camera and microphone
Exclusion Criteria
  • SI with plan or gesture (2 on HEADS ED; indicated plan or gesture)
  • Comorbid disorders (psychosis, schizophrenia, developmental disabilities, major substance abuse, and severe eating disorders).
  • Referring clinician has identified an externalizing disorder as a primary diagnosis or primary concern (e.g. Conduct Disorder)
  • Currently participating in regular psychotherapy at least one time per week
  • Currently under Children's Aid Society care
  • Currently in the CHEO ED on a Form 1 or Form 2, or placed on a Section 17.
  • Express difficulty with reading and writing

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group InterventionGroup InterventionThe intervention will consist of 6 psycho-educational group sessions for caregivers and 6 psycho-educational group sessions for adolescents. Adolescent and caregiver sessions will be held separately and will focus on different issues. Adolescents are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The groups consist of 6 stand-alone modules permitting rolling entry and prompt access. Youth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, homework from that week's intervention group and crisis resources.
Enhanced Treatment as UsualEnhanced Treatment as UsualYouth and Caregivers will receive a weekly text message reminder of their exit assessment date/time, a mental health tip and crisis resources.
Primary Outcome Measures
NameTimeMethod
Suicidal Ideation6 weeks

Suicidal ideation will be measured using the Suicidal Ideation Questionnaire Junior (Reynolds, 1988). A decreased score in suicidal ideation over 6-weeks will indicate a positive outcome.

Secondary Outcome Measures
NameTimeMethod
Depression and Anxiety6 weeks

We will be assessing youth depression and anxiety with the youth version of the Revised Child Anxiety and Depression Scale (Chorpita et al., 2000). A decreased score in depression and anxiety over 6-weeks will indicate a positive outcome.

Attachment6 weeks

We will be assessing caregiver attachment with the adolescent version of the Adolescent Attachment Anxiety \& Avoidance Inventory (Morretti \& Obsuth, 2009). A decreased score in attachment between the adolescent and caregiver over 6-weeks will indicate a positive outcome.

Family Functioning6 weeks

Family functioning using the Family Assessment Device (Epstein, Baldwin, \& Bishop, 1983). A decreased score in family functioning over 6-weeks will indicate a positive outcome.

Trial Locations

Locations (1)

CHEO

🇨🇦

Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath